6508Royal Perth Hospital, Perth, WA, Australia.
Curtin Medical School, Perth, WA, Australia.
Phlebology. 2022 Jul;37(6):469-475. doi: 10.1177/02683555221089614. Epub 2022 Apr 20.
Iliocaval stenting is widely used for treatment of symptomatic iliocaval obstruction. The aim of our study was to compare quality of life before and after iliocaval stenting.
Prospectively collected data using CIVIQ20 questionnaire, Venous Clinical Severity Score (rVCSS) and Villalta-Prandoni score (VP) of patients following iliocaval stenting for non-thrombotic and post-thrombotic venous obstruction were analysed.
One hundred and one limbs (87 patients) were stented between May 2017 and May 2019. Baseline CIVIQ20 median value was 50 (34-66); 1 month after surgery CIVIQ20 value was 36 (26-58) and the scores then remained steady for the rest of the first year. Both rVCSS and VP scores decrease by 3.09 (95% CI: 2.39, 3.89; < .001) and 5.21 (95% CI: 4.14, 6.48; < .001) units, respectively, throughout the first year.
Quality of life of patients with iliocaval obstruction significantly improves after successful percutaneous reconstruction. Severity of symptoms measured by rVCSS and VP scores decreases.
髂股静脉支架置入术广泛应用于治疗症状性髂股静脉阻塞。本研究旨在比较髂股静脉支架置入术前后的生活质量。
前瞻性收集了 2017 年 5 月至 2019 年 5 月接受非血栓性和血栓后静脉阻塞的髂股静脉支架置入术患者的 CIVIQ20 问卷、静脉临床严重程度评分（rVCSS）和 Villalta-Prandoni 评分（VP）的数据。
101 条肢体（87 例患者）接受了支架置入术。基线 CIVIQ20 中位数为 50（34-66）；术后 1 个月 CIVIQ20 值为 36（26-58），此后第一年评分保持稳定。rVCSS 和 VP 评分分别下降 3.09（95%CI：2.39，3.89；<0.001）和 5.21（95%CI：4.14，6.48；<0.001）单位。
髂股静脉阻塞患者经成功的经皮重建后生活质量显著改善。rVCSS 和 VP 评分测量的症状严重程度降低。
